Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

NCT00770874 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: S-1 + Cisplatin (arm A)
DRUG: Cisplatin (arm B)

Sponsor

Taiho Pharmaceutical Co., Ltd.